BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28459956)

  • 1. Adjuvant chemotherapy for large-cell neuroendocrine lung carcinoma: results from the European Society for Thoracic Surgeons Lung Neuroendocrine Tumours Retrospective Database.
    Filosso PL; Guerrera F; Evangelista A; Galassi C; Welter S; Rendina EA; Travis W; Lim E; Sarkaria I; Thomas PA;
    Eur J Cardiothorac Surg; 2017 Aug; 52(2):339-345. PubMed ID: 28459956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical management of atypical carcinoid and large-cell neuroendocrine carcinoma: a multicentre study on behalf of the European Association of Thoracic Surgeons (ESTS) Neuroendocrine Tumours of the Lung Working Group†.
    Filosso PL; Rena O; Guerrera F; Moreno Casado P; Sagan D; Raveglia F; Brunelli A; Welter S; Gust L; Pompili C; Casadio C; Bora G; Alvarez A; Zaluska W; Baisi A; Roesel C; Thomas PA;
    Eur J Cardiothorac Surg; 2015 Jul; 48(1):55-64. PubMed ID: 25406425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical response of large cell neuroendocrine carcinoma of the lung to perioperative adjuvant chemotherapy.
    Saji H; Tsuboi M; Matsubayashi J; Miyajima K; Shimada Y; Imai K; Kato Y; Usuda J; Kajiwara N; Uchida O; Ohira T; Hirano T; Mukai K; Kato H; Ikeda N
    Anticancer Drugs; 2010 Jan; 21(1):89-93. PubMed ID: 19770636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining the role of adjuvant therapy for early-stage large cell neuroendocrine carcinoma.
    Wakeam E; Adibfar A; Stokes S; Leighl NB; Giuliani ME; Varghese TK; Darling GE
    J Thorac Cardiovasc Surg; 2020 May; 159(5):2043-2054.e9. PubMed ID: 31759623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant Therapy for Patients With Early Large Cell Lung Neuroendocrine Cancer: A National Analysis.
    Raman V; Jawitz OK; Yang CJ; Tong BC; D'Amico TA; Berry MF; Harpole DH
    Ann Thorac Surg; 2019 Aug; 108(2):377-383. PubMed ID: 31004586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Systemic Therapy in the Management of Stage I Large Cell Neuroendocrine Carcinoma of the Lung.
    Kujtan L; Muthukumar V; Kennedy KF; Davis JR; Masood A; Subramanian J
    J Thorac Oncol; 2018 May; 13(5):707-714. PubMed ID: 29391287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Surgical results of large cell neuroendocrine carcinoma of the lung].
    Cağirici U; Cakan A; Samancilar O; Veral A; Ozhan M
    Tuberk Toraks; 2006; 54(1):30-3. PubMed ID: 16615015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large cell neuroendocrine carcinoma of the lung: a 10-year clinicopathologic retrospective study.
    Paci M; Cavazza A; Annessi V; Putrino I; Ferrari G; De Franco S; Sgarbi G
    Ann Thorac Surg; 2004 Apr; 77(4):1163-7. PubMed ID: 15063227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival and prognosis of lung large cell neuroendocrine carcinoma.
    Jiang H; Wu Q; Zhong Y
    Bull Cancer; 2021 Oct; 108(10):981-987. PubMed ID: 34392973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of large cell neuroendocrine histology in patients with pathologic stage Ia pulmonary non-small cell carcinoma.
    Iyoda A; Hiroshima K; Moriya Y; Sekine Y; Shibuya K; Iizasa T; Nakatani Y; Fujisawa T
    J Thorac Cardiovasc Surg; 2006 Aug; 132(2):312-5. PubMed ID: 16872955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic model of survival for typical bronchial carcinoid tumours: analysis of 1109 patients on behalf of the European Association of Thoracic Surgeons (ESTS) Neuroendocrine Tumours Working Group.
    Filosso PL; Guerrera F; Evangelista A; Welter S; Thomas P; Casado PM; Rendina EA; Venuta F; Ampollini L; Brunelli A; Stella F; Nosotti M; Raveglia F; Larocca V; Rena O; Margaritora S; Ardissone F; Travis WD; Sarkaria I; Sagan D;
    Eur J Cardiothorac Surg; 2015 Sep; 48(3):441-7; discussion 447. PubMed ID: 25564217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Immunotherapy in Stage IV Large Cell Neuroendocrine Carcinoma of the Lung.
    Komiya T; Ravindra N; Powell E
    Asian Pac J Cancer Prev; 2021 Feb; 22(2):365-370. PubMed ID: 33639649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large cell neuroendocrine carcinoma of the ampulla of Vater.
    Beggs RE; Kelly ME; Eltayeb O; Crotty P; McDermott R; Ridgway PF
    JOP; 2012 Sep; 13(5):470-5. PubMed ID: 22964952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinicopathological study of peripheral, small-sized high-grade neuroendocrine tumours of the lung: differences between small-cell lung carcinoma and large-cell neuroendocrine carcinoma.
    Isaka M; Nakagawa K; Ohde Y; Okumura T; Watanabe R; Ito I; Nakajima T; Kondo H
    Eur J Cardiothorac Surg; 2012 Apr; 41(4):841-6. PubMed ID: 22219429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical-pathologic analysis of 40 patients with large cell neuroendocrine carcinoma of the lung.
    Dresler CM; Ritter JH; Patterson GA; Ross E; Bailey MS; Wick MR
    Ann Thorac Surg; 1997 Jan; 63(1):180-5. PubMed ID: 8993262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of survival after operation among patients with large cell neuroendocrine carcinoma of the lung.
    Eichhorn F; Dienemann H; Muley T; Warth A; Hoffmann H
    Ann Thorac Surg; 2015 Mar; 99(3):983-9. PubMed ID: 25596870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical study of the expression of drug-resistant proteins in large cell neuroendocrine carcinoma of the lung.
    Okada D; Kawamoto M; Koizumi K; Tanaka S; Fukuda Y
    Jpn J Thorac Cardiovasc Surg; 2003 Jul; 51(7):272-6. PubMed ID: 12892456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Report from the European Society of Thoracic Surgeons prospective thymic database 2017: a powerful resource for a collaborative global effort to manage thymic tumours.
    Ruffini E; Guerrera F; Brunelli A; Passani S; Pellicano D; Thomas P; Van Raemdonck D; Rocco G; Venuta F; Weder W; Detterbeck F; Falcoz PE
    Eur J Cardiothorac Surg; 2019 Apr; 55(4):601-609. PubMed ID: 30649256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot study of adjuvant chemotherapy with irinotecan and cisplatin for completely resected high-grade pulmonary neuroendocrine carcinoma (large cell neuroendocrine carcinoma and small cell lung cancer).
    Kenmotsu H; Niho S; Ito T; Ishikawa Y; Noguchi M; Tada H; Sekine I; Watanabe S; Yoshimura M; Yamamoto N; Oshita F; Kubota K; Nagai K
    Lung Cancer; 2014 Jun; 84(3):254-8. PubMed ID: 24679951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative recurrence and the role of adjuvant chemotherapy in patients with pulmonary large-cell neuroendocrine carcinoma.
    Iyoda A; Hiroshima K; Moriya Y; Iwadate Y; Takiguchi Y; Uno T; Nakatani Y; Yoshino I
    J Thorac Cardiovasc Surg; 2009 Aug; 138(2):446-53. PubMed ID: 19619794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.